SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-009962
Filing Date
2021-04-28
Accepted
2021-04-28 17:25:54
Documents
10

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 788254
2 ex5-1.htm EX-5.1 31531
3 ex23-1.htm EX-23.1 3726
4 ex23-2.htm EX-23.2 3458
5 ex23-3.htm EX-23.3 3748
6 forms-3_001.jpg GRAPHIC 3710
7 forms-3_002.jpg GRAPHIC 3710
8 forms-3_003.jpg GRAPHIC 4655
9 forms-3_004.jpg GRAPHIC 13546
10 ex5-1_001.jpg GRAPHIC 1926
  Complete submission text file 0001493152-21-009962.txt   870472
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-254698 | Film No.: 21865690
SIC: 2835 In Vitro & In Vivo Diagnostic Substances